Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Interventional Oncology Devices Market Size And Revenue Outlook Through 2030#_x000D_
The interventional oncology devices market has experienced significant expansion recently. It is projected to grow from $2.5 billion in 2025 to $2.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. Historically, this expansion has been driven by factors such as an increase in cancer incidence rates, the proliferation of interventional radiology practices, enhancements in imaging technologies, a greater adoption of minimally invasive oncology treatments, and the presence of specialized oncology centers._x000D_
_x000D_
The interventional oncology devices market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach a valuation of $3.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the projection period include the escalating demand for specific cancer treatments, increased capital allocation in precision oncology, the proliferation of outpatient facilities for cancer care, the wider embrace of combined interventional treatment approaches, and innovations in ablation and embolization technologies. Key trends anticipated for the forecast timeframe encompass the expanding use of image-guided devices for tumor ablation, the growing preference for less invasive cancer treatment methods, the increasing implementation of embolization treatments, the broader application of precision oncology interventions, and improved integration of sophisticated imaging support systems._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Interventional Oncology Devices Market Growth Catalysts And Demand Drivers#_x000D_
The rising incidence of cancer is anticipated to drive the future expansion of the interventional oncology devices market. Cancer is defined as a collection of diseases marked by the unregulated proliferation and dispersion of unusual cells throughout the body, which can aggregate into masses or tumors. This widespread occurrence of cancer significantly elevates the demand for interventional oncology devices, which are crucial for the diagnosis, treatment, and ongoing management of the disease, facilitating early identification, staging, and monitoring. For example, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that the number of cancer cases diagnosed in Australia climbed from 160,570 in 2022 to 164,694 in 2023, representing a considerable increase over the period. This upward trajectory underscores the escalating prevalence of cancer nationwide. Thus, the high prevalence of cancer is a key factor propelling the growth of the interventional oncology devices market._x000D_
_x000D_
#Interventional Oncology Devices Market Segment Landscape And Growth Outlook#_x000D_
The interventional oncology devices market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Embolization Devices, Ablation Devices, Support Devices_x000D_
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization_x000D_
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types_x000D_
_x000D_
Subsegments:_x000D_
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents_x000D_
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices _x000D_
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems _x000D_
_x000D_
#Interventional Oncology Devices Market Trends Shaping Long-Term Demand#_x000D_
Leading companies within the interventional oncology devices market are concentrating on technologies, such as tissue volume, to enhance the accuracy of diagnoses and the effectiveness of treatment in oncology procedures. Tissue volume refers to the amount of biological tissue collected during a biopsy. Larger tissue volumes enable more comprehensive samples to be obtained, which improves diagnostic precision and the efficacy of treatment planning. As an illustration, in June 2023, Argon Medical, a US-based medical device company, launched the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage is designed to collect up to 35% more samples than leading competitors, thereby reducing the necessity for multiple passes during biopsies. This feature is critical for securing sufficient tissue samples for an accurate diagnosis._x000D_
_x000D_
#Interventional Oncology Devices Market Leading Players And Competitive Positioning#_x000D_
Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation _x000D_
_x000D_
#View The Full Interventional Oncology Devices Market Report:#_x000D_
_x000D_
#Interventional Oncology Devices Market Regional Split: Which Areas Are Fueling Growth?#_x000D_
North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model